Mulay James — SEC Form 4 filings
SEC reporting owner CIK 1684531. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-14.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-10-07 to 2026-07-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 9 filings — 123,197 shares, $6,279,034 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 24,165 shares @ $75.16 ($1,816,241) in CG Oncology, Inc., filed 2026-07-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CG Oncology, Inc. (CGON) | Director | 12 | — | 16 legs · 123,197 sh · $6,279,034 | 29 |
Form 4 filings — Mulay James
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-14 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 24,165 @ $26.63 · Sale (S): 24,165 @ $75.16 · Option exercise (M): 24,165 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 654 @ $3.72 · Sale (S): 654 @ $60.12 · Option exercise (M): 1,310 @ $12.59 · Sale (S): 1,310 @ $60.12 · Option exercise (M): 654 (derivative) @ $0 · Option exercise (M): 1,310 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | CG Oncology, Inc. (CGON) | Grant/award (A): 9,354 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 15,600 @ $36.63 · Sale (S): 15,600 @ $73.01 · Option exercise (M): 15,600 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 654 @ $3.72 · Sale (S): 654 @ $63.50 · Option exercise (M): 1,310 @ $12.59 · Sale (S): 1,310 @ $63.50 · Option exercise (M): 654 (derivative) @ $0 · Option exercise (M): 1,310 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 654 @ $3.72 · Sale (S): 654 @ $44.16 · Option exercise (M): 10,491 @ $12.59 · Sale (S): 10,491 @ $52.99 · Option exercise (M): 654 (derivative) @ $0 · Option exercise (M): 10,491 (derivative) @ $0 | EDGAR |
| 2025-10-10 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 5,903 @ $3.72 · Sale (S): 5,903 @ $43.99 · Option exercise (M): 5,903 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 12,755 @ $1.82 · Sale (S): 12,755 @ $39.19 · Option exercise (M): 12,755 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 19,112 @ $1.82 · Sale (S): 19,112 @ $39.01 · Option exercise (M): 3,574 @ $1.82 · Sale (S): 3,574 @ $38.99 · Option exercise (M): 19,112 (derivative) @ $0 · Option exercise (M): 3,574 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | CG Oncology, Inc. (CGON) | Option exercise (M): 27,015 @ $0.60 · Sale (S): 12,342 @ $30.47 · Sale (S): 4,095 @ $31.42 · Sale (S): 7,465 @ $32.64 · Sale (S): 3,113 @ $33.22 · Option exercise (M): 27,015 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | CG Oncology, Inc. (CGON) | Grant/award (A): 24,165 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | CG Oncology, Inc. (CGON) | Grant/award (A): 15,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1684531 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →